Suppr超能文献

透析患者高血压的饮食限钠

Dietary sodium restriction for hypertension in dialysis patients.

作者信息

Ahmad Suhail

机构信息

Nephrology Section, Department of Medicine, University of Washington, and the Scribner Kidney Center, Seattle, Washington 98133, USA.

出版信息

Semin Dial. 2004 Jul-Aug;17(4):284-7. doi: 10.1111/j.0894-0959.2004.17328.x.

Abstract

A close relationship between sodium and hypertension exists and this relationship is even more pronounced in renal failure and dialysis patients. Hypertension is one of the strongest predictors of poor outcome in dialysis patients. Almost all end-stage renal disease (ESRD) patients have hypertension and positive sodium balance, resulting in extracellular volume (ECV) expansion-the most important contributing factor to hypertension. Thus the effective management of hypertension requires normalization of the sodium balance and ECV. Two important methods to achieve this are limiting interdialytic weight gain (IDWG) and a dialysis process that is able to remove all IDWG and consistently attain dry weight. Since IDWG is directly dependent on sodium intake and the resulting thirst, sodium restriction is the most effective way to limit IDWG. Ultrafiltration and dialysate sodium concentration influence sodium removal, ECV control, and blood pressure (BP) control. Thus the dialysis session should be long enough to achieve dry weight and frequent enough to maintain appropriate BP.

摘要

钠与高血压之间存在密切关系,这种关系在肾衰竭和透析患者中更为明显。高血压是透析患者预后不良的最强预测因素之一。几乎所有终末期肾病(ESRD)患者都有高血压和钠正平衡,导致细胞外液量(ECV)扩张,这是高血压最重要的促成因素。因此,有效控制高血压需要使钠平衡和ECV正常化。实现这一目标的两个重要方法是限制透析间期体重增加(IDWG)以及采用能够清除所有IDWG并持续达到干体重的透析过程。由于IDWG直接取决于钠摄入量和由此产生的口渴感,限制钠摄入是限制IDWG的最有效方法。超滤和透析液钠浓度会影响钠清除、ECV控制和血压(BP)控制。因此,透析疗程应足够长以达到干体重,且频率应足够高以维持适当的血压。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验